Aldeyra (ALDX) announced receipt of a complete response letter from the FDA for the resubmission of the new drug application of reproxalap, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback